Published in Drug Week, June 13th, 2008
Prior to today in China, Propess was indicated for cervix dilation to help induce labor, and is currently distributed via vaginal inserts that are 1.1 mm thick. The birth rate in China averages approximately 1.2%, which results in about 16 million births each year. Further, about 18% of pregnant women require cervical dilation, including 3% of women with Premature Rupture of Membranes (PROM).
The IDL approved today will enable BMP Sunstone to market and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2008-06-13)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.